Open Access Open Access  Restricted Access Subscription or Fee Access

Innovation Practices in Biopharma, MedTech, and Digital Medicine

Arthur A Boni


Section two applies the principles presented and summarized in Section One to the production side of the healthcare industry, and consists of 7 chapters (or contributed articles). Our focus is on biopharma (the converged pharma and biotech segments), MedTech, and digital medicine. We also include a discussion on areas of convergence of technology, healthcare, and biopharma as the broader industry has begun adoption of a customer-centric business model that incorporates solutions that merge drugs, devices, and digital technology to impact the entire healthcare system.

Full Text:



  • There are currently no refbacks.